Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanisms.

MLA

Stubbs, Brianna J., et al. “Rationale and Protocol for a Safety, Tolerability and Feasibility Randomized, Parallel Arm, Double-Blind, Placebo-Controlled, Pilot Study of a Novel Ketone Ester Targeting Frailty via Immunometabolic Geroscience Mechanisms.” PLoS ONE, vol. 19, no. 9, Sept. 2024, pp. 1–19. EBSCOhost, https://doi.org/10.1371/journal.pone.0307951.

APA

Stubbs, B. J., Alvarez Azañedo, G., Peralta, S., Diaz, S. R., Gray, W., Alexander, L., Silverman-Martin, W., Garcia, T. Y., Blonquist, T. M., Upadhyay, V., Turnbaugh, P. J., Johnson, J. B., & Newman, J. C. (2024). Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanisms. PLoS ONE, 19(9), 1–19. https://doi.org/10.1371/journal.pone.0307951

Chicago

Stubbs, Brianna J., Gabriela Alvarez Azañedo, Sawyer Peralta, Stephanie Roa Diaz, Wyatt Gray, Laura Alexander, Wendie Silverman-Martin, et al. 2024. “Rationale and Protocol for a Safety, Tolerability and Feasibility Randomized, Parallel Arm, Double-Blind, Placebo-Controlled, Pilot Study of a Novel Ketone Ester Targeting Frailty via Immunometabolic Geroscience Mechanisms.” PLoS ONE 19 (9): 1–19. doi:10.1371/journal.pone.0307951.